Clinical Trial: Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07169240) titled 'Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects' on Aug. 17.

Brief Summary: This study is a single-center, randomized, double-blind, placebo-controlled, single dose escalation design to evaluate the safety, tolerability, and pharmacokinetic characteristics of BT-114143 Injection.

Study Start Date: Feb. 06, 2023

Study Type: INTERVENTIONAL

Condition: Healthy Subjects (HS)

Intervention: DRUG: BT-114143

6 subjects will receive a single dose of BT-114143 injection at 0.03 mg/kg.

DRUG: BT-114143

6 subjects will receive a single dose of BT-114143 injection at 0....